515 related articles for article (PubMed ID: 27231347)
21. O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.
Zhang Z; Tan EP; VandenHull NJ; Peterson KR; Slawson C
Front Endocrinol (Lausanne); 2014; 5():206. PubMed ID: 25520704
[TBL] [Abstract][Full Text] [Related]
22. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
23. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
[TBL] [Abstract][Full Text] [Related]
24. O-GlcNAcylation and neurodegeneration.
Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of a missense mutation in the
Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
[No Abstract] [Full Text] [Related]
26. OGT: a short overview of an enzyme standing out from usual glycosyltransferases.
Aquino-Gil M; Pierce A; Perez-Cervera Y; Zenteno E; Lefebvre T
Biochem Soc Trans; 2017 Apr; 45(2):365-370. PubMed ID: 28408476
[No Abstract] [Full Text] [Related]
27. O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.
Nagel AK; Ball LE
Amino Acids; 2014 Oct; 46(10):2305-16. PubMed ID: 25173736
[TBL] [Abstract][Full Text] [Related]
28. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
29. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
[TBL] [Abstract][Full Text] [Related]
30. Ac
Wang H; Guo J; Wang N; Wang J; Xue Q; Wang J; Liu W; Liu K; Cao X; Zhao W; Xi R; Niu Y; Wang P; Li J
Bioorg Med Chem Lett; 2019 Mar; 29(6):802-805. PubMed ID: 30713024
[TBL] [Abstract][Full Text] [Related]
31. Role of the GATA-1/FOG-1/NuRD pathway in the expression of human beta-like globin genes.
Miccio A; Blobel GA
Mol Cell Biol; 2010 Jul; 30(14):3460-70. PubMed ID: 20439494
[TBL] [Abstract][Full Text] [Related]
32. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.
Stephen HM; Adams TM; Wells L
Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085
[TBL] [Abstract][Full Text] [Related]
33. Functional significance of O-GlcNAc modification in regulating neuronal properties.
Hwang H; Rhim H
Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
[TBL] [Abstract][Full Text] [Related]
34. '
Zhao L; Shah JA; Cai Y; Jin J
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082668
[TBL] [Abstract][Full Text] [Related]
35. A genetic model to study
St Amand MM; Bond MR; Riedy J; Comly M; Shiloach J; Hanover JA
J Biol Chem; 2018 Aug; 293(35):13673-13681. PubMed ID: 29954943
[No Abstract] [Full Text] [Related]
36. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy decreases O-GlcNAc-modified proteins in systemic arteries of normotensive and spontaneously hypertensive rats.
Troiano JA; Potje SR; Graton ME; Silva DS; da Costa RM; Tostes RC; Antoniali C
Life Sci; 2021 Feb; 266():118885. PubMed ID: 33316265
[TBL] [Abstract][Full Text] [Related]
38. Chemical and Biochemical Strategies To Explore the Substrate Recognition of O-GlcNAc-Cycling Enzymes.
Hu CW; Worth M; Li H; Jiang J
Chembiochem; 2019 Feb; 20(3):312-318. PubMed ID: 30199580
[TBL] [Abstract][Full Text] [Related]
39. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
[TBL] [Abstract][Full Text] [Related]
40. Molecular Interrogation to Crack the Case of O-GlcNAc.
Estevez A; Zhu D; Blankenship C; Jiang J
Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]